U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908083) titled 'Analytical Treatment Interruption After Combination bNAb Therapy' on April 01.
Brief Summary: The purpose of this research study is to see if and when HIV levels in the blood (viral load) rise after the participant stops their HIV medication. We will also measure the highest number (peak) of the virus before each participant starts their HIV medications again. For most people treated with standard HIV medications, the HIV virus amount will increase within 2 to 4 weeks after stopping their HIV medications. This study is only open to participants who have taken part in an earlier study (MCA-1034 or NIH #001037). In the earlier study, ...